COMMUNIQUÉS West-GlobeNewswire

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

30/03/2018 - 22:01

REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - March 30, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]

More Than 20 Cerner Executives Earn Board Certification in Health Care Management

30/03/2018 - 22:01

KANSAS CITY, Mo., March 30, 2018 (GLOBE NEWSWIRE) -- Cerner announced that 21 of its associates recently earned the distinction of board certification in health care management as Fellows of the American College of [...]

SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results

30/03/2018 - 21:15

SAN RAMON, Calif., March 30, 2018 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq: STDY ), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with [...]

Radius Health Initiates Phase 3 Clinical Trial of Abaloparatide Injection for the Treatment of Male Osteoporosis

30/03/2018 - 20:32

WALTHAM, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ) announced today that the company has initiated the Phase 3 ATOM ( A baloparatide T reatment for O steoporosis in M ales) study of [...]

NANOBIOTIX : Nanobiotix 2017 Annual Results

30/03/2018 - 16:03

Nanobiotix 2017 Annual Results Paris, France and Cambridge, Massachusetts, USA, March 30, 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to [...]

NANOBIOTIX : Nanobiotix : Résultats Annuels 2017

30/03/2018 - 16:03

Nanobiotix : Résultats Annuels 2017 Paris, France, et Cambridge, Massachusetts (USA) le 30 mars 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), société française pionnière en nanomédecine développant de [...]

Abiomed to Appoint New Chief Financial Officer Todd A. Trapp

30/03/2018 - 15:06

DANVERS, Mass., March 30, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Todd A. Trapp will be appointed as Vice President and [...]

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

30/03/2018 - 14:00

BOSTON, March 30, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]

NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL-YEAR 2017 FINANCIAL RESULTS

30/03/2018 - 07:31

PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS PROVIDES CORPORATE UPDATE AND REPORTS FULL-YEAR 2017 FINANCIAL RESULTS COMPLETED PATIENT ENROLLMENT IN PHASE IIb CLINICAL STUDY OF IFNalpha KINOID FOR TREATMENT OF [...]

NÉOVACS : RÉSULTATS ANNUELS 2017 ET POINT SUR LES AVANCÉES OPÉRATIONNELLES

30/03/2018 - 07:31

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE RÉSULTATS ANNUELS 2017 ET POINT SUR LES AVANCÉES OPÉRATIONNELLES FIN DU RECRUTEMENT DES PATIENTS DANS L'ÉTUDE CLINIQUE DE PHASE IIb AVEC l'IFNalpha [...]

MedMira Reports Second Quarter Results

30/03/2018 - 01:00

HALIFAX, Nova Scotia, March 29, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2018. Profit and Loss Highlights Revenue: The Company [...]

Scythian Biosciences Announces Extension of Letter of Intent

30/03/2018 - 00:51

TORONTO, March 29, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company " or “ Scythian ”) (TSXV:SCYB) (Frankfurt: 9SB ) (OTC – Nasdaq Intl:SCCYF) announced today that the Company has signed an agreement [...]

DiaMedica Therapeutics Announces Final Closing of Private Placement

30/03/2018 - 00:08

MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ” and “ DiaMedica ”) (TSX-V: DMA ) (OTCQB:DMCAF) is pleased to announce the successful completion of the second and final [...]

K2M Names Lane Major Chief Operating Officer

29/03/2018 - 22:45

LEESBURG, Va., March 29, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]

Mustang Bio Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Corporate Highlights

29/03/2018 - 22:30

NEW YORK, March 29, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]

Chimerix Announces Martha J. Demski as Board Chair; Appoints New Members to Board of Directors

29/03/2018 - 22:30

DURHAM, N.C., March 29, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced the appointment of Martha J. Demski as [...]

Reata Announces That Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan

29/03/2018 - 22:15

IRVING, Texas, March 29, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced that its licensee, Kyowa Hakko Kirin Co. Ltd [...]

CohBar, Inc. Announces Closing of First Tranche of Private Placement

29/03/2018 - 22:10

MENLO PARK, Calif., March 29, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) (TSXV:COB.U) (“CohBar” or the “Company”) is pleased to announce the closing of its first tranche of its previously announced private [...]

resTORbio Reports Fourth Quarter and Full Year 2017 Financial Results

29/03/2018 - 22:05

BOSTON, March 29, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of [...]